Daiwa Securities Group
TEVA icon

Daiwa Securities Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Daiwa Securities Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-757
Closed -$105K – 1016
2017
Q1 		$105K Buy
+757
New +$25.8K ﹤0.01% 888
2016
Q4 		– Sell
-500
Closed -$53K – 1054
2016
Q3 		$53K Buy
+500
New +$26.1K ﹤0.01% 873

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Daiwa Securities Group's TEVA Position: Q2 2026 in Review

Daiwa Securities Group increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 10% in Q2 2026, buying an estimated $370K and bringing the position to 117,065 shares worth $3.97M. The position accounts for 0.01% of the portfolio, ranked #564.

Daiwa Securities Group first reported a position in TEVA in Q2 2016 and has held it in 41 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Daiwa Securities Group held 117,065 shares of Teva Pharmaceutical Industries Limited worth $3.97M as of Q2 2026.
  • Daiwa Securities Group bought 11,100 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $370K.
  • Teva Pharmaceutical Industries Limited made up 0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #564 holding.
  • Daiwa Securities Group first reported a position in Teva Pharmaceutical Industries Limited in Q2 2016 and has held it in 41 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.